NKGN Company Profile and Key Details

NASDAQ : NKGN

NKGen Biotech Common Stock

$0.00

0.0001+5.00%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

NKGen Biotech, Inc. Common Stock (NKGN) stock surged +5.00%, trading at $0.00 on OTC, up from the previous close of $0.00. The stock opened at $0.00, fluctuating between $0.00 and $0.00 in the recent session.

Stock Snapshot

0.002

Prev. Close

274.27K

Market Cap

0.0021

Day Low

-0.01

P/E Ratio

-1.33

EPS (TTM)

-1

Cash Flow per Share

Open

130.6M

Number of Shares

0.0021

Day High

10.35%

Free Float in %

-1.85

Book Value

400

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 09, 2026	0.00	0.00	0.00	0.00	400
Sep 04, 2026	0.00	0.00	0.00	0.00	1.9K
Sep 03, 2026	0.00	0.00	0.00	0.00	1.5K
Aug 31, 2026	0.00	0.08	0.00	0.01	2.16K
Aug 27, 2026	0.00	0.00	0.00	0.00	3.77K
Aug 26, 2026	0.00	0.00	0.00	0.00	1.5K
Aug 25, 2026	0.00	0.00	0.00	0.00	2K
Aug 24, 2026	0.01	0.01	0.01	0.01	200
Aug 19, 2026	0.01	0.01	0.01	0.01	2K
Aug 17, 2026	0.01	0.01	0.01	0.01	265
Aug 11, 2026	0.01	0.01	0.01	0.01	500
Aug 10, 2026	0.01	0.01	0.01	0.01	2.06K
Aug 04, 2026	0.01	0.01	0.01	0.01	3.07K
Jul 30, 2026	0.06	0.06	0.00	0.01	140.14K
Jul 27, 2026	0.06	0.06	0.06	0.06	1.38K
Jul 23, 2026	0.06	0.06	0.06	0.06	1.47K
Jul 22, 2026	0.15	0.15	0.06	0.06	76.29K
Jul 21, 2026	0.06	0.06	0.06	0.06	2.32K
Jul 17, 2026	0.06	0.06	0.06	0.06	1.61K
Jul 14, 2026	0.06	0.06	0.06	0.06	4K

Contact Details

Santa Ana, CA 92705

United States

https://nkgenbiotech.com 949 396 6830

About Company

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. The company develops SNK01, an autologous NK cell therapy candidate in Phase I/IIa trial for the treatment of neurodegenerative diseases, such as Alzheimer’s and Parkinson's disease; and SNK02, which consists of an allogenic NK cell therapy that has completed Phase 1 trial and a HER2-CAR NK cell therapy candidate in pre-clinical trial to treat refractory solid tumors. It has a strategic partnership with HekaBio K.K., a Japan-based healthcare platform, to develop, conduct clinical trials, obtain regulatory approvals, manufacture, and commercialize the company’s autologous NK cell therapy product candidates for central nervous system and autoimmune conditions in Japan. The company also has a license agreement with NKMAX Co., Ltd. for the research and development of its NK cell program. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current NKGen Biotech, Inc. Common Stock (NKGN) stock price?

NKGen Biotech, Inc. Common Stock (OTC: NKGN) stock price is $0.00 in the last trading session. During the trading session, NKGN stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in NKGN stock occurred in the recent session was 5% while the dollar amount for the price change in NKGN stock was $0.00.

NKGN's industry and sector of operation?

The OTC listed NKGN is part of Biotechnology industry that operates in the broader Healthcare sector. NKGen Biotech, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NKGN?

No Data

How NKGN did perform over past 52-week?

NKGN's closing price is 110% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.77 is -99.72%.

How many employees does NKGN have?

Number of NKGN employees currently stands at 26.

Link for NKGN official website?

Official Website of NKGN is: https://nkgenbiotech.com

How do I contact NKGN?

NKGN could be contacted at phone 949 396 6830 and can also be accessed through its website. NKGN operates from 3001 Daimler Street, Santa Ana, CA 92705, United States.

How many shares of NKGN are traded daily?

NKGN stock volume for the day was 400 shares. The average number of NKGN shares traded daily for last 3 months was 6.8K.

What is the market cap of NKGN currently?

The market value of NKGN currently stands at $274.27K with its latest stock price at $0.00 and 130.6M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	26
Beta	0.72
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	26
Beta	0.72
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

NKGN Company Profile and Key Details

NKGen Biotech Common Stock

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook